Upload
phungkien
View
215
Download
0
Embed Size (px)
Citation preview
Orodispersible drug delivery systems
Disintegrate and/or dissolve rapidly in the saliva without the need for water.
Tablets Films
Fast-dissolving Fast- disintegrating
tablets are designed to dissolve in saliva remarkably
fast, within a few seconds
contain agents to enhance the rate of tablet disintegration in
the oral cavity
Orodispersible drug delivery systems
European Pharmacopoeia adopted the term “Orodispersible Tablet” as a tablet that to be placed
in oral cavity where it disperses rapidly before swallowing.
There are multiple fast-dissolving OTC and Rx products on the market worldwide
There is increases in the number of new chemical entities under development using a fast-dissolving
drug delivery technology. Anti-ulcer (e.g. Omeprazole), antiasthamatics
(salbutamol sulphate), antitussives, expectorants, antihistaminics, NSAID’S (e.g. paracetamol,
meloxicam, valdecoxib).
•Ease of administration for patients who are mentally ill, disabled and uncooperative. •Requires no water •Self administration. •Overcomes unacceptable taste of the drugs and could provide a pleasant mouth feel. •Allows high drug loading. •Provide advantages of liquid medication in the form of solid preparation. •Adaptable to existing processing and packaging machinery. •Increased bioavailability (pre-gastric absorption ).
Advantages of orodispersible dosage forms
While the claimed increase in bioavailability is
disputable, it is clear that the major advantage of
these formulations is convenience
Advantages of orodispersible dosage forms
The fast-dissolving property of the tablet is attributable to a quick ingress of water into the tablet matrix resulting in its rapid disintegration.
Approaches for orodispersible Tablets
The basic approaches to developing orodispersible dosage forms tablets are: •Maximizing the porous structure of the tablet matrix •Incorporating the appropriate disintegrating agent •Using highly water-soluble excipients
Lyophilization
Tablet Molding
Direct compression
Spray drying
Sublimation
Mass extrusion
Conventional Techniques Used in the Preparation of Orodispersible Tablets
Freeze drying or Lyophilization
A process in which water is sublimated from the product after
freezing.
Scanning electron images of orodispersible tablets prepared by lyophilization
Freeze drying or Lyophilization
Advantages: Tablets are highly porous, with a very high specific surface area, which dissolve rapidly and show improved absorption and bioavailability. Disadvantages: Tablets are fragile with low mechanical strength, which make them difficult to handle and require special packaging. They are hygroscopic and exhibit poor stability on storage under stressed conditions.
Freeze drying or Lyophilization
Molding
moistening the powder blend with a suitable solvent followed by putting into mold plates.
The solvent is then removed.
Molding
Compression molding
Heat molding
No-vacuum lyophilization
Drying solidified agar at -300C under
vacuum
Evaporate a frozen mixture containing a
gum at standard pressure
Air drying of a hydroalcoholic
solvent
Moulded tablets typically do not possess great mechanical strength. Erosion and breakage of the
moulded tablet often occur during handling and opening of blister packs.
The formulations contained: •Gelatin as a support agent for the matrix •Mannitol as a bulking agent •Na starch glycolate or crosscarmellose as a disintegrant. The formulation was spray dried to yield a porous free flowing powder. Tablets manufactured from this powder disintegrated in less than 20 s in an aqueous medium.
Spray drying
Drug solution or slurry is sprayed
Steam of hot gas
Drug powder
Solvent evaporation
Spray drying
Sublimation
Conventional compressed tablets containing highly
water-soluble ingredients and volatile ingredients. The
volatile material is removed by sublimation, leaving
behind a porous matrix.
Sublimation
Inert solid ingredients that displayed high volatility :
ammonium bicarbonate ammonium carbonate
benzoic acid Camphor
hexamethonium tetramine Naphthalene
phthalic anhydride Urea
Urethane cyclohexane & benzene
water
Sublimation
Advantages: •Easy •Conventional equipment •Commonly available excipients •Limited number of processing steps •High doses can be accommodated
Direct compression
Direct compression
Disintegrants Sugar-based excipients dextrose, fructose, isomalt, maltitok, maltose,
mannitol, sorbitol, starch hydrolyse, polydextrose, and xylitol
Effervescent disintegrating
agents
Superdisintegrants
Microcrystalline cellulose crospovidone croscarmellose Na
This technology involves softening the active blend using the solvent mixture of water soluble polyethylene glycol, using methanol and expulsion of softened mass through the extruder or syringe to get a cylinder of the product into even segments using heated blade to form tablets.
Mass extrusion
Mass extrusion
Patented Technologies for orodispersible Tablets
Some patented technologies are available. Each technology has a different mechanism, and each fast-dissolving/disintegrating dosage form varies regarding the following: -Mechanical strength of final product; -Drug and dosage form stability; -Mouth feel; -Taste; -Rate of dissolution of drug formulation in saliva; -Swallowability; -Rate of absorption from the saliva solution; and -Overall bioavailability.
Zydis Technology
The first marketed fast dissolving tablet.
Produced by lyophilizing
Usually consisting of gelatin
Tablet properties: •Dissolves in the mouth within seconds. •Very lightweigh, fragile, and must be dispensed in a special blister pack. •Self-preserving because the final water concentration in the freeze-dried product is too low to allow for microbial growth. •The drug amount is less than 60 mg for soluble drugs. •Particle size of insoluble drugs between 50-200mm to prevent sedimentation during processing. •Has poor stability at higher temperatures and humidities.
Zydis Technology
Orasolv Technology
A fast-disintegrating tablet with drug microparticles and effervescent disintegrant.
Prepared by conventional blenders and tablet equipment using Less force of compaction.
OraSolv products disintegrate rapidly in the mouth without chewing. Drug microparticles are released and swallowed as a slurry or suspension. Complete dissolution and systemic absorption occurs in the GI tract. Typically, the pharmacokinetics are matched to the reference product.
Orasolv Technology
Tablet properties:
Their disintegration time is less than 30s.
The OraSolv formulations are not very hygroscopic.
This technology involves taste masking of active drug.
Tablets are soft and fragile
They require a special handling and packaging system.
Durasolv Technology
Produced in a fashion similar to OraSolv with much higher mechanical strength. Tablets are durable and can be packaged in traditional blister packaging, pouches or vials. This technology is best suited for formulations including relatively small doses of active compound.
This technology utilizes a unique spinning mechanism (flash heat processing)
Flash Dose Technology
Shearform technology Ceform technology
A floss-like crystalline structure to incorporate the active drug and be compressed into a tablet
Small spheres of saccharides to carry the drug
It has a very high surface area for dissolution. It disperses and dissolves quickly once placed onto the tongue.
The formed microspheres serves as a method of taste masking.
•The tablet can accommodate only up to 600 mg drug.
•Tablets produced are highly friable, soft and moisture
sensitive. Therefore specialized packing is required.
Tablet properties:
Flash Dose Technology
Wowtab Technology “With Out Water”
This process uses a combination of two different types of saccharides combined to obtain a tablet formulation with adequate hardness and fast dissolution rate.
low mouldability saccharides (rapid dissolution)
high mouldability saccharide (good binding property).
•The Wowtab product are stable •Suitable for both conventional bottle and blister packaging. •Offer superior mouth feel •Tablets dissolves quickly in 15 seconds
Wowtab Technology “With Out Water”
Tablet properties:
Flashtab Technology
Rapidly disintegrating tablet consisting of an
active ingredient in the form of microcystals
coacervation microencapsulation extrusion-spheronization
pan coating
The microcrystals of the active ingredient are added to the granulated mixture of excipients prepared by wet or dry granulation, and compressed into tablets.
Flashtab Technology
Utilize the conventional tabletting technology
Tablets have good mechanical strength
Disintegration time less than 1 min.
Taste-masking
Tablet properties:
Oraquick Technology
Fast-dissolving/disintegrating tablet
formulation utilizes a patented taste masking
microsphere technology, known as MicroMask
technology.
Oraquick Technology
•The process does not utilize solvents of any kind, this
leads to faster and more efficient production.
•Appropriate for heat-sensitive drugs.
•Good taste-masking.
•Tablets can be compressed to achieve significant
mechanical strength without disrupting taste masking.
Has quick dissolution in a matter of seconds
Tablet properties:
NanoCrystal particles are small particles of drug substance, typically less than 1000 nm in diameter, which are produced by milling the drug substance using a proprietary wet milling technique
Nanocrystal Technology
NanoCrystal colloidal dispersions of drug substance are combined with water-soluble ingredients, filled into blisters and lyophilized.
•The wafers dissolve in very small quantities of water in seconds. •Attractive for highly potent drugs because manufacturing losses are negligible •For hazardous materials because it avoids manufacturing operations (e.g., granulation, blending, and tableting) that generate large quantities of aerosolized powder and present much higher risk of exposure.
Nanocrystal Technology
Product properties:
Evaluation tests for orodispersible tablets
?
In-vitro In-vivo
Fast-dissolving films are gaining interest as an
alternative to fast-dissolving tablets to definitely
eliminate patients’ fear of chocking and
overcome patent impediments.
Fast-dissolving films
Examples for film-forming polymers: modified starches (maltodextrin), gums (xanthan & guar gum), cellulose ethers, alginates, polyvinylalcohols, polyvinylpyrrolidones or blends
They dissolve in saliva requiring no water to take.
Plasticizers •Are important factors affecting mechanical properties of films (such as tensile strength and elongation) •Variation in their concentration may affect these properties. •The commonly used plasticizers are glycerol, dibutylpthallate and polyethylene glycols
Fast-dissolving films
Manufacturing Methods 1) Solvent casting. 2) Semisolid casting. 3) Hot melt extrusion. 4) Solid dispersion extrusion. 5) Rolling.
Fast-dissolving films
Solvent casting method water soluble polymers are dissolved in water and the
drug along with other additives is dissolved in suitable solvent then both the solutions are mixed, stirred and finally casted in to the Petri plate, and dried.
Aqueous solution
Solvent
Evaluation of fast-dissolving films
•Film thickness •Film flexibility •Tensile properties •Stickiness determination •Drug content •Disintegration test •Measurement of the disintegration in the oral cavity •In vitro dissolution test
Fast-dissolving films
TECHNOLOGIES
1) SOLULEAVES™ technology
2) WAFERTAB™
3) FOAMBURST™
4) XGEL™ film
5) Quick –Dis Technology
Fast-dissolving films
Quick –Dis Technology
A thin, flexible and quick-dissolving film
•Provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. •The typical disintegration time is only 5 to 10 seconds. •The dissolving time (at which not less than 80% of the tested film is dissolved in aqueous media) is around 30 seconds •The typical release profile of an active ingredient exhibited by a Quick-Dis™ drug delivery system is 50% released within 30 seconds and 95% within 1 minute.
Film properties: